Pharma Solutions offers full molecular diagnostics capabilities utilizing various platforms to accommodate a variety of analyses. Its state-of-the-art molecular laboratory is technology-agnostic and equipped with the most innovative platforms, covering next-generation sequencing (NGS), genotyping, NanoString services, liquid biopsies, etc. We are a certified services provider for various companies such as Thermo Fisher, ArcherDx, NanoString, etc. and offer full NGS capabilities with both Illumina and Thermo Fisher Platforms, providing a mix of proprietary panels and off-the-shelf assays. Pharma Solutions comprehensive menu of validated assays is ready for direct use in your oncology and non-oncology programs.
Pharma Solutions is transforming global drug development with our comprehensive suite of molecular diagnostic solutions that will help identify more qualified target populations for clinical studies and optimize the safety and efficacy of therapeutic compounds. The result is an overall improvement in Return on Investment, an important consideration in the landscape of escalating drug discovery and development costs.
Development and Label Expansion
All of our expression analyses are available for integration into clinical studies. Custom assay development and validation services are offered to address client-specific requests. Pharma Solutions applies rigorous quality standards, including GLP and CLIA, to all studies in order to ensure the highest quality data is generated and reported. We are able to quantify gene expression in a broad spectrum of tissue samples, including formalin fixed paraffin embedded (FFPE) tissues specimens.